In conclusion, our study demonstrated that elevated expression of RPS15A is closely correlated with poor prognosis of GC patients and promotes EMT and GC progression via Akt/IKK‐β/NF‐κB signalling pathway, thus possibly providing a promising candidate for treatment against GC metastasis. The gene discussed is RPS15A; the disease is gastric cancer.